Patents by Inventor Masayuki Miyasaka

Masayuki Miyasaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060211651
    Abstract: A persulfated saccharide compound capable of acting on selectin and chemokine. According to the present invention, there are provided a saccharide compound capable of interacting with L-selectin, P-selectin and chemokine; a pharmaceutical composition; and an agent for treating or preventing a disease of which sideration is associated with biological events mediated by any of L-selectin, P-selectin and chemokine.
    Type: Application
    Filed: January 29, 2003
    Publication date: September 21, 2006
    Applicant: Taisho Pharmaceutical Co., Ltd.
    Inventors: Masayuki Miyasaka, Hiroto Kawashima
  • Patent number: 5981509
    Abstract: The specification relates to a preparation for the prophylaxis or treatment of renal diseases, and a method for the prophylaxis or treatment of renal diseases, and specifically, it relates to the above preparation and method using a sulfated polysaccharide as an active ingredient.
    Type: Grant
    Filed: May 20, 1997
    Date of Patent: November 9, 1999
    Assignee: Shiseido Company, Ltd.
    Inventors: Kazuo Akima, Kenichi Shikata, Hirofumi Makino, Zensuke Ota, Kyoji Hirata, Masayuki Miyasaka, Yasuo Suzuki
  • Patent number: 5872109
    Abstract: Use of a polysaccharide selected from the group consisting of sulfated acid mucopolysaccharides and sulfated dextrans, and physiologically acceptable salts thereof for prophylaxis or treatment of inflammations, particularly an adult respiratory distress syndrome (ARDS), ischemic heart diseases, ischemic cerebral diseases, chronic articular rheumatism, atopic dermatitis, and infiltration after organ implantation.
    Type: Grant
    Filed: October 4, 1996
    Date of Patent: February 16, 1999
    Assignee: Shiseido Company, Ltd.
    Inventors: Kazuo Akima, Peter A. Ward, Masayuki Miyasaka, Yasuo Suzuki
  • Patent number: 5449756
    Abstract: The present invention is directed to recombinant the IL-21R.beta. chain or fragments thereof, cDNA coding therefore, vectors containing said cDNA, hosts transfected by said vectors, and monoclonal antibodies to said recombinant IL-2R.beta. or fragments thereof.
    Type: Grant
    Filed: July 9, 1993
    Date of Patent: September 12, 1995
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Tadatsugu Taniguchi, Masanori Hatakeyama, Sejiro Minamoto, Takeshi Kono, Takeshi Doi, Masayuki Miyasaka, Mitsuru Tsudo, Hajime Karasuyama
  • Patent number: 5317537
    Abstract: A multi-port memory device has a memory cell array including one or more memory blocks each of which has a plurality of memory cells arranged in rows and columns, and a plurality of dummy cells, with one dummy cell being provided for each row of memory cells in each of the memory blocks so that the dummy cells are connected with associated ones of the word lines extending in the row direction. The dummy cells are further connected with dummy cell bit lines extending in the column direction. Sense amplifiers are connected to receive outputs of those memory cells in the memory cell array which are selected in a memory cell selection operation and outputs of those dummy cells among the plurality of dummy cells which are selected in the memory cell selection operation for amplifying differences between the selected memory cell outputs and the selected dummy cell outputs. Precharging and shielding arrangements are also provided for improved operation.
    Type: Grant
    Filed: May 27, 1992
    Date of Patent: May 31, 1994
    Assignees: Hitachi, Ltd., Hitachi VLSI Engineering Corp.
    Inventors: Satoshi Shinagawa, Yoichi Sato, Masami Hasegawa, Yasushi Shimono, Masayuki Miyasaka, Takatoshi Tamura, Yoshio Iioka
  • Patent number: 5198359
    Abstract: The present invention is directed to recombinant IL-2R.mu. protein or fragments thereof, cDNA coding therefore, vectors containing this cDNA, hosts transfected by these vectors, and monocional antibodies to the encoded recombinant IL-2R.mu. protein or fragments thereof.
    Type: Grant
    Filed: March 5, 1990
    Date of Patent: March 30, 1993
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Tadatsugu Taniguchi, Masanori Hatakeyama, Sejiro Minamoto, Takeshi Kono, Takeshi Doi, Masayuki Miyasaka, Mitsuru Tsudo, Hajime Karasuyma